Related Experiment Videos
Insights
This study found a significant association between HLA-A3 and chronic active hepatitis (CAH) in patients. The HLA-A3/Bw35 combination also showed increased frequency and risk in individuals with CAH.
Area of Science:
- Immunogenetics
- Hepatology
- Human Leukocyte Antigen (HLA) system
Background:
- Chronic active hepatitis (CAH) is an inflammatory liver condition.
- The Human Leukocyte Antigen (HLA) system plays a crucial role in immune responses.
- Genetic predispositions, particularly HLA associations, are investigated in various diseases.
Purpose of the Study:
- To investigate the association between specific HLA alleles and chronic active hepatitis (CAH).
- To determine the frequency of HLA-A and HLA-B loci alleles in CAH patients.
- To evaluate the relative risk associated with specific HLA allele combinations in CAH.
Main Methods:
- HLA typing for 24 alleles of the A and B loci was performed on 42 patients diagnosed with CAH.
- Diagnosis adhered to European Association for the Study of the Liver criteria.
- Case-control comparison with 266 healthy individuals.
Main Results:
- A significantly increased frequency of HLA-A3 was observed in CAH patients (47.6%) compared to controls (19.1%), with a relative risk of 3.83.
- The phenotypic association HLA-A3/Bw35 was also significantly increased in CAH patients (28.5%) versus controls (6.0%), yielding a relative risk of 6.25.
- Family studies confirmed the presence of the HLA-A3/Bw35 haplotype in affected families.
Conclusions:
- The HLA-A3 allele is strongly associated with chronic active hepatitis.
- The combined HLA-A3/Bw35 haplotype represents a significant genetic risk factor for developing CAH.
- These findings contribute to understanding the immunogenetic basis of CAH.
Abstract:
42 patients (33 males and 9 females) with chromic active hepatitis (CAH) mostly HBsAg+, were typed for 24 alleles of the A and B loci. Diagnosis was performed according to the criteria outlined by the European Association for the Study of the Liver. The increased frequency of HLA-A3 (47.6% instead of 19.1% in 266 healthy controls) is significant after correction. The relative risk is 3.83. The phenotypic association A3/Bw35 is also increased (28.5% instead of 6.0 in the control group). The risk of the A3/Bw35 association is 6.25. The risk of A3 calculated in patients lacking Bw35 is 1.6. A family study in 5 patients over 5 showed an haplotype A3/Bw35.